Exhibit 107

Calculation of Filing Fee Table

424(b)(5)

(Form Type)

EMERGENT BIOSOLUTIONS INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Primary

Fees to Be Paid

Equity

Common Stock, par value $0.001 per share

457(o) and 457(r)(1)

N/A

N/A

$150,000,000

0.00011020

$16,530

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Total Offering Amounts

$150,000,000

$16,530

Total Fees Previously Paid

N/A

Total Fee Offsets

N/A

Net Fee Due

$16,530

(1) The filing fee is calculated and is being paid pursuant to Rules 456(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price. The registrant initially deferred payment of the registration fees for its Registration Statement on Form S-3 (File No. 333-258634) filed by the Registrant with the Securities and Exchange Commission on August 9, 2021 pursuant to Rules 456(b) and 457(r) under the Securities Act.